Phathom Pharmaceuticals, Inc. (PHAT) Total Assets by Year
Phathom Pharmaceuticals, Inc. closed fiscal year 2025 with $259.1M in total assets, $697.3M in total liabilities and -$438.2M in shareholder equity. This represents a decrease of 31.5% from the prior fiscal year. The table below carries 8 fiscal years, from 2018 to 2025, and the quarters Phathom Pharmaceuticals, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
PHAT Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $259.1M-31.5% | $378.3M-8.6% | $413.8M+151.1% | $164.8M-13.0% | $189.4M-35.8% | $295.1M+14.7% | $257.2M+28412.0% | $902K |
| Total Liabilities | $697.3M+10.4% | $631.9M+29.9% | $486.6M+103.1% | $239.6M+104.3% | $117.3M+16.3% | $100.8M+245.1% | $29.2M+1235.6% | $2.2M |
| Total Equity | -$438.2M-72.8% | -$253.6M-248.5% | -$72.8M+2.7% | -$74.8M-203.7% | $72.2M-62.9% | $194.3M-14.8% | $228.0M+17825.9% | -$1.3M |
PHAT Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $327.1M+30.7% | $305.1M+3.7% | $259.1M-31.5% | $240.3M-37.9% | $250.2M-21.7% | $294.2M-17.5% | $378.3M-8.6% | $387.0M+63.3% | $319.4M+20.5% | $356.5M+147.6% | $413.8M+151.1% | $237.0M+17.4% |
| Total Liabilities | $671.3M+2.3% | $642.1M+1.5% | $697.3M+10.4% | $662.8M+15.4% | $656.1M+18.6% | $632.6M+25.3% | $631.9M+29.9% | $574.2M+125.4% | $553.2M+123.6% | $505.0M+115.6% | $486.6M+103.1% | $254.8M+11.6% |
| Total Equity | -$344.3M+15.2% | -$337.0M+0.4% | -$438.2M-72.8% | -$422.5M-125.8% | -$405.8M-73.6% | -$338.4M-127.9% | -$253.6M-248.5% | -$187.1M-952.8% | -$233.8M-1428.6% | -$148.5M-64.6% | -$72.8M+2.7% | -$17.8M+32.7% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Phathom Pharmaceuticals, Inc. financials
Frequently Asked Questions
What was Phathom Pharmaceuticals, Inc.'s total assets in fiscal year 2025?
Phathom Pharmaceuticals, Inc. closed fiscal year 2025 with $259.1M in total assets, $697.3M in total liabilities and -$438.2M in shareholder equity.
How fast is Phathom Pharmaceuticals, Inc.'s total assets growing?
Phathom Pharmaceuticals, Inc. (PHAT) total assets fell by 31.5% year over year, from $378.3M to $259.1M in fiscal year 2025.
How has Phathom Pharmaceuticals, Inc.'s total assets changed over the years?
Across the 8 fiscal years this page covers, Phathom Pharmaceuticals, Inc. (PHAT) total assets went from $902K in fiscal year 2018 to $259.1M in fiscal year 2025.
What was Phathom Pharmaceuticals, Inc.'s total assets in the most recent quarter?
Phathom Pharmaceuticals, Inc. (PHAT) reported $327.1M in total assets in Q2 2026. This represents an increase of 30.7% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Phathom Pharmaceuticals, Inc. (PHAT) reported on that line in every period on record.